Skip to content

Insider · CIK 0001903360

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

Reports to the SEC for 6 companies · BOSTON, MA

Transactions

15

Companies

6

Filings

6

CIK

0001903360

Forms 4 and 5

Insider transactions

15 trades
DateCompanyValue
2026-05-01AVLNAvalyn Pharma Inc.C Conversion—
2026-05-01AVLNAvalyn Pharma Inc. · Series C-1 Convertible Preferred StockC Conversion—
2026-05-01AVLNAvalyn Pharma Inc. · Series D Convertible Preferred StockC Conversion—
2025-01-30MTSRMetsera, Inc.C Conversion—
2025-01-30MTSRMetsera, Inc. · Series B Preferred StockC Conversion—
2024-10-15UPBUpstream Bio, Inc.C Conversion—
2024-10-15UPBUpstream Bio, Inc. · Series B redeemable convertible preferred stockC Conversion—
2024-09-16MBXMBX Biosciences, Inc.C Conversion—
2024-09-16MBXMBX Biosciences, Inc.C Conversion—
2024-09-16MBXMBX Biosciences, Inc. · Series B Preferred StockC Conversion—
2024-09-16MBXMBX Biosciences, Inc. · Series C Preferred StockC Conversion—
2023-11-14CARGO Therapeutics, Inc.C Conversion—
2023-11-14CARGO Therapeutics, Inc.Series A-1 Preferred StockC Conversion—
2023-09-19RayzeBio, Inc.C Conversion—
2023-09-19RayzeBio, Inc.Series D Preferred StockC Conversion—